Xing Chen

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Venues

The New England journal of medicine

Nature medicine

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Justin F Gainor, Manish R Patel, Jeffrey S Weber, Martin Gutierrez, Julie E Bauman, Jeffrey M Clarke, Ricklie Julian, Aaron James Scott, Jessica L Geiger, Kedar S Kirtane, Celine Robert-Tissot, Brandon Coder, Moomal Tasneem, Jing Sun, Wei Zheng, Lauren Gerbereux, Andressa Laino, Filippos Porichis, Jack Pollard, Peijie Hou, Vasudha Sehgal, Xing Chen, Manju Morrissey, Hikmat N Daghestani, Igor Feldman, Lakshmi Srinivasan, Joshua P Frederick, Michelle Brown, Praveen Aanur, Robert Meehan, Howard A Burris
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study. Cancer discovery (2024)
Spyros Chalkias, Jordan L Whatley, Frank Eder, Brandon Essink, Shishir Khetan, Paul Bradley, Adam Brosz, Nichole McGhee, Joanne E Tomassini, Xing Chen, Xiaoping Zhao, Andrea Sutherland, Xiaoying X Shen, Bethany Girard, Darin K Edwards, Jing Feng, Honghong Zhou, Stephen R Walsh, David C Montefiori, Lindsey R Baden, Jacqueline M Miller, Rituparna Das
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results. Nature medicine (2023)
Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R Walsh, Brandon Essink, Adam Brosz, Nichole McGhee, Joanne E Tomassini, Xing Chen, null Ying Chang, Andrea Sutherland, David C Montefiori, Bethany Girard, Darin K Edwards, null Jing Feng, Honghong Zhou, Lindsey R Baden, Jacqueline M Miller, Rituparna Das
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19. Nature communications 14 (1) (2023)
Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R Walsh, Brandon Essink, Adam Brosz, Nichole McGhee, Joanne E Tomassini, Xing Chen, Ying Chang, Andrea Sutherland, David C Montefiori, Bethany Girard, Darin K Edwards, Jing Feng, Honghong Zhou, Lindsey R Baden, Jacqueline M Miller, Rituparna Das
A Bivalent Omicron-Containing Booster Vaccine against Covid-19. The New England journal of medicine 387 (14) (2022)
Spyros Chalkias, Frank Eder, Brandon Essink, Shishir Khetan, Biliana Nestorova, Jing Feng, Xing Chen, Ying Chang, Honghong Zhou, David Montefiori, Darin K Edwards, Bethany Girard, Rolando Pajon, Frank J Dutko, Brett Leav, Stephen R Walsh, Lindsey R Baden, Jacqueline M Miller, Rituparna Das
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial. Nature medicine 28 (11) (2022)
Spyros Chalkias, Jing Feng, Xing Chen, Honghong Zhou, Jean-Claude Marshall, Bethany Girard, Joanne E Tomassini, Barbara J Kuter, David C Montefiori, Rituparna Das
Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination. The New England journal of medicine 387 (23) (2022)

Xing Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xing Chen